The critical-infrastructure provider said the purchase is expected to extend fluid-management services into Europe, Middle East and Africa after a North America-focused PurgeRite close.

Demand comments stayed positive and outlook turned constructive even as avocado prices and tequila volumes weighed.

PEO and Insurance Solutions revenue rose 12% to $367.6 million as Management Solutions growth cooled to 4%.

Organic revenue growth reached 8.9% and gross margin hit a record 51.5% of sales in the quarter ended Aug. 31, 2026.

Fourth-quarter net sales were $6.6 billion, up 5.6%, as gross profit as a percentage of sales reached 53.3%.

Seven selected compounds place investigational programs alongside approved treatments, with trial design and patient setting shaping every comparison.

The sponsor’s induction readout advances the TL1A program, with detailed results and separate maintenance evidence still important.

Nine selected compounds span approved treatments, new mechanisms and dosing schedules; unlike trials cannot establish a simple efficacy ranking.

The investigational therapy combines GLP-1 activation with GIP blockade; durability and tolerability remain central questions.

Etrasimod’s approval rests on placebo-controlled evidence, including a year-long study whose design differs from responder-only maintenance trials.

A potential liver-injury case preceded the April 2025 decision; completed trial records do not signal an active program.

RenaissanceRe's property book swung from a 148.7% combined ratio to 34.1% in a single year, and the relief is already showing up as give-back in reinsurance pricing.

Disney quantified how much of its subscription growth came from the Fubo transaction, while affiliate-dependent peers reported accelerating basic-subscriber losses and unchanged risk language on the pace of the shift.

Cloud-metric disclosures across the sector show recurring revenue accelerating at some companies and cooling at others, even as risk-factor hedging on cloud adoption and renewal rates stayed largely unchanged.

Mechanics Bancorp said the sale of the substantial majority of runoff auto loans will reduce risk, improve liquidity and enhance future profitability.

Boston Scientific (BSX) issued a Class I recall of the ENROUTE Transcarotid Neuroprotection System after the FDA cited potential arterial sheath tip separation during use.

The device maker pulled the ENROUTE Transcarotid Neuroprotection System Plus after the FDA classified a Class I recall over potential arterial sheath tip separation.

The asset manager will pay $3.38 a share in cash, citing industrials expertise and the US housing ecosystem as it takes the global maker private.

The agriculture technology company will hand shareholders one Vylor share for each Corteva share as it splits crop protection from seed.

Torrid Holdings disclosed a concrete drop in Chinese sourcing while Oxford Industries and V F Corp flagged new uncertainty over whether tariff refunds owed to them will ever arrive.

Corcept Therapeutics told investors the Inflation Reduction Act's inflation rebates may materially cut its revenue and profits in 2026 and beyond, one of the sharpest company-specific warnings in a filing season otherwise dominated by boilerplate recitations of the same 2022 law.

The two utilities proposed doubling residential bill credits to four years and adding 1,000 direct Virginia jobs as part of their pending all-stock combination.

Four GameStop insiders added 1.07 million shares in a week, the largest cluster of the period.

Remaining performance obligations rose $209 billion year-over-year to $664 billion after more than $30 billion of new AI cloud contracts.

Second-quarter identical sales without fuel rose 0.2% as the company lowered its full-year range to 0.2%–0.8%.

The software company lifted full-year fiscal 2026 revenue targets to $26.576 billion to $26.626 billion after a third-quarter beat.

The foodservice distributor said the deal would create a preeminent multi-channel foodservice distribution platform.

The analog chipmaker said the purchase accelerates its “Physical Intelligence” push, pairing Alif’s digital processing with ADI’s sensing, power, and connectivity stack.

The convenience chain posted diluted earnings of $7.37 a share in the three months ended July 31, 2026, as fuel margin offset a 0.3% drop in same-store gallons.

Sonida Senior Living put a dollar figure on labor inflation that most peers still describe only in hedged, forward-looking terms.